Actively Recruiting

Phase 3
Age: 22Years +
All Genders
NCT05561127

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

Led by GIE Medical · Updated on 2025-06-25

171

Participants Needed

33

Research Sites

447 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To determine the safety and efficacy of GIE Medical's ProTractX3™ TTS DCB for the treatment of recurrent benign bowel strictures.

CONDITIONS

Official Title

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

Who Can Participate

Age: 22Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 22 years or older
  • Diagnosis of symptomatic benign bowel stricture with at least 2 previous dilations
  • Willing and able to complete protocol required follow up
  • Willing and able to provide written informed consent
  • Stricture length 5 cm or less
Not Eligible

You will not qualify if you...

  • Female subjects who are pregnant, breastfeeding, or plan to get pregnant in the next 12 months
  • Contraindication to endoscopy, anesthesia, or deep sedation
  • Suspicion of malignant bowel stricture
  • Benign stricture due to extrinsic compression
  • Stricture is not amenable to standard balloon dilation (e.g., severe angulation, unable to pass guidewire)
  • Stricture complicated with abscess, fistula, perforation, leakage, or varices
  • Moderate to severe active inflammation in the stricture segment at treatment time
  • Multiple significant strictures unable to be treated with a single balloon (total length must be 5 cm or less)
  • Received steroid injections into target stricture in the last 8 weeks
  • Stricture cannot be dilated to at least 15 mm in small bowel or 18 mm in large bowel
  • Diagnosis of metastatic cancer not in remission or non-metastatic cancer requiring pelvic radiation
  • Suspected gastrointestinal tract perforation
  • Active systemic infection
  • Allergy to paclitaxel
  • Severe coagulation disorders or use of anticoagulant/antiplatelet medication not safely managed
  • Chronic systemic steroid use above 10 mg/day unless willing to undergo 4-week washout
  • Condition requiring urgent treatment
  • Life expectancy less than 24 months
  • Concurrent medical conditions affecting safety or evaluation
  • Current participation in another pre-market drug or medical device clinical study unless in long-term follow-up

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 33 locations

1

Honor Health

Scottsdale, Arizona, United States, 85258

Actively Recruiting

2

University of California, Irvine

Irvine, California, United States, 92697-7600

Actively Recruiting

3

Gastro Care Institute

Lancaster, California, United States, 93534

Actively Recruiting

4

Cedars Sinai

Los Angeles, California, United States, 90048

Actively Recruiting

5

San Diego Gastroenterology

San Diego, California, United States, 92103

Actively Recruiting

6

University of Colorado Anschutz

Aurora, Colorado, United States, 80045

Actively Recruiting

7

University of Florida

Gainesville, Florida, United States, 32610

Actively Recruiting

8

Borland-Groover

Jacksonville, Florida, United States, 32256

Actively Recruiting

9

Research Associates of South Florida

Miami, Florida, United States, 33134

Actively Recruiting

10

Hillcrest Medical Research

Orange City, Florida, United States, 32763

Not Yet Recruiting

11

Orlando Health

Orlando, Florida, United States, 32806

Actively Recruiting

12

Orlando Health

Orlando, Florida, United States, 32806

Actively Recruiting

13

Gastroenterology Associates of Central Georgia, LLC

Macon, Georgia, United States, 31210

Actively Recruiting

14

Rush University

Chicago, Illinois, United States, 60612

Actively Recruiting

15

Kansas Gastroenterology, LLC

Wichita, Kansas, United States, 67226

Actively Recruiting

16

University of Louisville

Louisville, Kentucky, United States, 40202

Actively Recruiting

17

Tandem Clinical Research

Marrero, Louisiana, United States, 70072

Actively Recruiting

18

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

19

Washington University

St Louis, Missouri, United States, 63130

Actively Recruiting

20

Rutgers University

Piscataway, New Jersey, United States, 08854

Actively Recruiting

21

New York Presbyterian Hospital- Columbia University Medical Center

New York, New York, United States, 10027

Actively Recruiting

22

Lenox Hill Hospital

New York, New York, United States, 10075

Actively Recruiting

23

University of North Carolina

Chapel Hill, North Carolina, United States, 27599-1350

Actively Recruiting

24

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

25

Einstein Medical Center

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

26

Thomas Jefferson University

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

27

Allegheny Health Network

Pittsburgh, Pennsylvania, United States, 15212

Actively Recruiting

28

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 27232

Actively Recruiting

29

Baylor St. Luke's Medical Center

Houston, Texas, United States, 77030

Actively Recruiting

30

The University of Utah

Salt Lake City, Utah, United States, 84108

Actively Recruiting

31

Virginia Mason

Seattle, Washington, United States, 98101

Actively Recruiting

32

Swedish Medical Center

Seattle, Washington, United States, 98122

Actively Recruiting

33

West Virginia University

Morgantown, West Virginia, United States, 26501

Actively Recruiting

Loading map...

Research Team

E

Erika Wang

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here